- Home
- FBIO vs SER Comparison
FBIO vs SER Comparison
Compare FBIO & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- SER
- Stock Information
- Founded
- FBIO 2006
- SER 2017
- Country
- FBIO United States
- SER United States
- Employees
- FBIO N/A
- SER N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- FBIO Health Care
- SER Health Care
- Exchange
- FBIO Nasdaq
- SER Nasdaq
- Market Cap
- FBIO 58.3M
- SER 56.5M
- IPO Year
- FBIO N/A
- SER 2018
- Fundamental
- Price
- FBIO $1.97
- SER $5.40
- Analyst Decision
- FBIO Strong Buy
- SER Strong Buy
- Analyst Count
- FBIO 2
- SER 2
- Target Price
- FBIO $21.00
- SER $13.00
- AVG Volume (30 Days)
- FBIO 219.9K
- SER 23.9K
- Earning Date
- FBIO 08-12-2025
- SER 08-08-2025
- Dividend Yield
- FBIO N/A
- SER N/A
- EPS Growth
- FBIO N/A
- SER N/A
- EPS
- FBIO N/A
- SER N/A
- Revenue
- FBIO $57,784,000.00
- SER $51,000.00
- Revenue This Year
- FBIO $51.59
- SER N/A
- Revenue Next Year
- FBIO $44.74
- SER N/A
- P/E Ratio
- FBIO N/A
- SER N/A
- Revenue Growth
- FBIO N/A
- SER N/A
- 52 Week Low
- FBIO $1.33
- SER $3.81
- 52 Week High
- FBIO $2.66
- SER $11.57
- Technical
- Relative Strength Index (RSI)
- FBIO 55.60
- SER 45.42
- Support Level
- FBIO $1.90
- SER $5.11
- Resistance Level
- FBIO $2.02
- SER $5.67
- Average True Range (ATR)
- FBIO 0.10
- SER 0.38
- MACD
- FBIO -0.00
- SER -0.01
- Stochastic Oscillator
- FBIO 72.73
- SER 38.52
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.